These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 16037970)

  • 1. Modeling and simulations of the pharmacokinetics of fluorophore conjugated antibodies in tumor vicinity for the optimization of fluorescence-based optical imaging.
    Fibich G; Hammer A; Gannot G; Gandjbakhche A; Gannot I
    Lasers Surg Med; 2005 Aug; 37(2):155-60. PubMed ID: 16037970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical antisense imaging of tumor with fluorescent DNA duplexes.
    Liu X; Wang Y; Nakamura K; Liu G; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2007; 18(6):1905-11. PubMed ID: 17939728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data.
    Baxter LT; Yuan F; Jain RK
    Cancer Res; 1992 Oct; 52(20):5838-44. PubMed ID: 1394212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
    Fujimori K; Covell DG; Fletcher JE; Weinstein JN
    J Nucl Med; 1990 Jul; 31(7):1191-8. PubMed ID: 2362198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance and surface plasmon field-enhanced fluorescence spectroscopy for sensitive detection of tumor markers.
    Arima Y; Teramura Y; Takiguchi H; Kawano K; Kotera H; Iwata H
    Methods Mol Biol; 2009; 503():3-20. PubMed ID: 19151933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody binding.
    Dahle J; Krogh C; Melhus KB; Kaalhus O; Larsen RH; Stokke T
    Nucl Med Commun; 2007 Sep; 28(9):742-7. PubMed ID: 17667754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A finite element model for protein transport in vivo.
    Sadegh Zadeh K; Elman HC; Montas HJ; Shirmohammadi A
    Biomed Eng Online; 2007 Jun; 6():24. PubMed ID: 17598901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling.
    Gleisner KS; Nickel M; Lindén O; Erlandsson K; Wingårdh K; Strand SE
    J Nucl Med; 2007 Aug; 48(8):1369-78. PubMed ID: 17673426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging biomarkers of inflammation in situ with functionalized quantum dots in the dextran sodium sulfate (DSS) model of mouse colitis.
    Karwa A; Papazoglou E; Pourrezaei K; Tyagi S; Murthy S
    Inflamm Res; 2007 Dec; 56(12):502-10. PubMed ID: 18210234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Monte Carlo simulation of the Philips Allegro/GEMINI PET systems using GATE.
    Lamare F; Turzo A; Bizais Y; Le Rest CC; Visvikis D
    Phys Med Biol; 2006 Feb; 51(4):943-62. PubMed ID: 16467589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF; El-Emir E; Boxer GM; Qureshi U; Dearling JL; Robson MP; Begent RH; Trott KR; Pedley RB
    Clin Cancer Res; 2008 May; 14(9):2639-46. PubMed ID: 18451227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia.
    Lim K; Chan P; Dinniwell R; Fyles A; Haider M; Cho YB; Jaffray D; Manchul L; Levin W; Hill RP; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):126-33. PubMed ID: 17768016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model.
    Chvetsov AV; Dong L; Palta JR; Amdur RJ
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):595-602. PubMed ID: 19596173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
    McCabe A; Dolled-Filhart M; Camp RL; Rimm DL
    J Natl Cancer Inst; 2005 Dec; 97(24):1808-15. PubMed ID: 16368942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolabeling for correlative light and electron microscopy on ultrathin cryosections.
    Kandela IK; Bleher R; Albrecht RM
    Microsc Microanal; 2008 Apr; 14(2):159-65. PubMed ID: 18312726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor search with diffusion-weighted imaging--first experience].
    Bohlscheid A; Nuss D; Lieser S; Busch HP
    Rofo; 2008 Apr; 180(4):302-9. PubMed ID: 18370348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a phase array diffuse optical tomographic imager.
    Rajan K; Vijayakumar V; Biswas SK; Vasu RM
    Rev Sci Instrum; 2008 Aug; 79(8):084301. PubMed ID: 19044366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.